Hôpital Henri-Mondor AP-HP

62 currently recruiting clinical trials
Create patient profile for matching
Phase 2 Colon cancer Rectal cancer Anal cancer Pancreas cancer Liver and bile duct cancer Stomach and esophageal cancer #NCT06475352
Required disease stage
Locally Advanced Metastatic
Required number of previous lines of therapy for current stage of disease
None
Required previous treatments at advanced or metastatic stage
Systemic Treatment-Naive
Hôpital Henri-Mondor AP-HP (Créteil)
UNICANCER
Phase 1 / Phase 2 Lymphoma #NCT06090539
Required histologic types
B cell lymphoma
Required central nervous system lesions
None
Required number of previous lines of therapy
1 2 3 or more
Excluded previous treatments
Systemic Treatment-Naive
Hôpital Henri-Mondor AP-HP (Créteil)
Bristol-Myers Squibb
Phase 1 / Phase 2 Lymphoma CLL & Richter's syndrome #NCT05006716
Required histologic types
B cell lymphoma CLL (Chronic Lymphocytic Leukemia) Richter's syndrome
Required histologic sub types
Large B cell lymphoma Mantel cell lymphoma Follicular lymphoma Marginal zone lymphoma Waldenström lymphoma Lymphocytic lymphoma
Required central nervous system lesions
None
Required number of previous lines of therapy
1 2 3 or more
Excluded previous treatments
Systemic Treatment-Naive
Hôpital Henri-Mondor AP-HP (Créteil)
BeOne Medecines
Phase 1 / Phase 2 Prostate cancer #NCT07190300 #2025-521873-15-00
Required histologic sub types
Adenocarcinoma
Required disease stage
Metastatic Hormone-sensitive
Required number of previous lines of therapy for current stage of disease
None
Required previous treatments at localized stage
Hormone therapy
Required previous treatments at advanced or metastatic stage
Hormone therapy
Excluded previous treatments at advanced or metastatic stage
Internal Vectorised Radiotherapy (IVR)
Hôpital Henri-Mondor AP-HP (Créteil)
Novartis
Phase 1 / Phase 2 Acute leukemia #NCT05580861 #2024-513084-38-00
Required histologic types
Acute myeloid leukemia (AML)
Required central nervous system lesions
None
Required renal function statuses
> 60 ml/min 50-60 ml/min
Required number of previous lines of therapy
None
Required previous treatments
Systemic Treatment-Naive
Excluded genetic anomalies
FLT3-ITD
Hôpital Henri-Mondor AP-HP (Créteil)
Assistance Publique - Hôpitaux de Paris
Phase 1 / Phase 2 Lymphoma #NCT06495723 #2023-509648-88-00
Escalade et extension de dose
Required histologic types
T cell lymphoma
Required histologic sub types
Peripheral T cell lymphoma
Required central nervous system lesions
None
Required number of previous lines of therapy
1 2 3 or more
Required previous treatments
Chemotherapy
Excluded previous treatments
Systemic Treatment-Naive
Hôpital Henri-Mondor AP-HP (Créteil)
Xenothera SAS
Phase 1 / Phase 2 Lymphoma #NCT07018752 #2024-514954-63-00
Required histologic types
T cell lymphoma
Required histologic sub types
Peripheral T cell lymphoma
Required central nervous system lesions
None
Required renal function statuses
> 60 ml/min 50-60 ml/min 30-50 ml/min
Required number of previous lines of therapy
1 2 3 or more
Excluded previous treatments
Systemic Treatment-Naive
Hôpital Henri-Mondor AP-HP (Créteil)
The Lymphoma Academic Research Organisation (LYSARC)
Phase 1 Lymphoma CLL & Richter's syndrome #NCT05828459
Required number of previous lines of therapy
1 2 3 or more
Excluded previous treatments
Systemic Treatment-Naive
Hôpital Henri-Mondor AP-HP (Créteil)
Onward Therapeutics
Phase 1 Multiple myeloma #NCT05137054 #2020-004638-39
Cohortes 1 à 6
Required histologic types
Symptomatic multiple myeloma
Required histologic sub types
Monoclonal component measurable
Required central nervous system lesions
None
Required number of previous lines of therapy
2 3 or more
Required previous treatments
Monoclonal antibodies Proteasome inhibitor Immunomodulator
Excluded previous treatments
Systemic Treatment-Naive Autologous stem cell transplant Allogeneic stem cell transplant
Hôpital Henri-Mondor AP-HP (Créteil)
Regeneron Pharmaceuticals
Phase 1 Lymphoma CLL & Richter's syndrome #NCT05544019 #2023-505204-34-00
Required histologic types
B cell lymphoma CLL (Chronic Lymphocytic Leukemia)
Required central nervous system lesions
None Treated / Controled
Required number of previous lines of therapy
1 2 3 or more
Excluded previous treatments
Systemic Treatment-Naive
Hôpital Henri-Mondor AP-HP (Créteil)
Schrödinger, Inc.